Skip to content

Clinical trials

Completed Fabry Disease trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fabry Disease Status: Completed Country / region: Italy Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20121
20151
20161
20171
20184
20191
20212
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amicus Therapeutics3
Chiesi Farmaceutici S.p.A.3
Protalix2
CENTOGENE GmbH Rostock1
Chiesi Italia1
Federico II University1
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1
Idorsia Pharmaceuticals Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fabry Disease17
Proteinuria4
CADASIL1
Cardiomyopathies1
Disease1
Heart Diseases1
Lysosomal Storage Diseases1
Moyamoya Disease1
Sneddon Syndrome1
Stroke1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.